✦ LIBER ✦

Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials

✍ Scribed by Frances A. Shepherd; Frank V. Fossella; Thomas Lynch; Jean-Pierre Armand; James R. Rigas; Mark G. Kris

Book ID: 114105442
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 602 KB
Volume: 28
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(01)90297-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel (Taxotere) shows survival and

Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials

✍ Frances A Shepherd; Frank V Fossella; Thomas Lynch; Jean-Pierre Armand; James R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Phase III trial comparing paclitaxel pol

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

✍ Paz-Ares, L; Ross, H; O'Brien, M; Riviere, A; Gatzemeier, U; Von Pawel, J; Kauke 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

PD-069 Quality-of-Life (COL) assessment

PD-069 Quality-of-Life (COL) assessment in two docetaxel dose-schedulesas second-line treatment of advanced non small cell lung cancer (NSCLC): Spanish Lung Cancer Group (SLCG) Phase III trial

✍ Camps, C.; Massuti, B.; Jiménez, A.; Maestu, I.; Garcia, R.; Isla, M.; González- 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB

A Randomized Phase II Trial of Oral Topo

A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer

✍ Suzanne Jones; Dana Thompson; John Barton; Jeff Patton; Dianna Shipley; F. Antho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 124 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB

A phase I trial of the combination taxot

A phase I trial of the combination taxotere® (docetaxel) and cisplatin in patients with advanced non-small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB